Optometrists in San Tan Valley, AZ Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Clasik Vision Care Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 3125 W Hunt Hwy # B-102, San Tan Valley, AZ 85142 Phone: 480-525-2025 Fax: 480-422-8749 |
 Bradley Bywater, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 85 W Combs Rd Ste 108, San Tan Valley, AZ 85140 Phone: 602-239-4286 |
Matthew Gillon, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 85 W Combs Rd Ste 108, San Tan Valley, AZ 85140 Phone: 602-239-4286 |
Dr. Anthony Jon Drew, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 85 W Combs Rd Ste 108, San Tan Valley, AZ 85140 Phone: 602-239-4286 Fax: 602-474-2324 |
News Archive
Environmental toxin exposure may disrupt function of circadian clock, research shows
Can environmental toxins disrupt circadian rhythms - the biological "clock" whose disturbance is linked to chronic inflammation and a host of human disorders? Research showing a link between circadian disruption and plankton that have adapted to road salt pollution puts the question squarely on the table.
New genetic function involved in embryo development in organisms
Research aimed at understanding the mechanisms underlying embryo development has taken a step forward thanks to collaborative work between biologists specialized in the study of the fruit fly (Drosophila melanogaster) and scientists specialized in the design of mathematical models that simulate the functioning of biological systems.
Elegant, efficient way to find recombinant SARS-CoV-2 viruses from >85,000 genomes
The low divergence of near-identical genomes that are sequenced in short periods presents a statistical challenge that is not addressed by methods available currently. In a recent bioRxiv** paper, Ales Varabyou et al. from John Hopkins University present an efficient method designed to detect recombination and reassortment events between clades of viral genomes – a new algorithm called ‘Bolotie'.
Findings support development of cysteine protease inhibitors as new drug target for AD
A team of scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer's disease (AD). Moreover, the candidate inhibitor drug has been shown to be safe in humans.
› Verified 7 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Audiologists